Important notice regarding Inveltys

Posted in Latest News on August 7, 2019.

Important notice regarding Inveltys:

The board approved Inveltys (loteprednol etabonate ophthalmic suspension) 1% for addition to Rule 64B13-18.002. Effective August 5, 2019, Licensees are now permitted to prescribe Inveltys.



More Latest News

Announcing the FY 2022-23 Annual Report and Long-Range Plan
November 1, 2023

An annual publication showcasing trends and information about Florida’s health care regulatory landscape. Continue reading →


Hurricane Idalia: Early Prescription Refills Permitted Under State of Emergency
August 27, 2023

On August 26, 2023, Governor Ron DeSantis declared a state of emergency to prepare for Hurricane Idalia. Continue reading →




Survey Button